Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects

Clinical trial NCT05328726 · COMPLETED

Trial details

NCT number: NCT05328726
Sponsor: Gan and Lee Pharmaceuticals, USA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2022-03-08
Primary completion: 2023-02-09
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.